Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. - Wikidata - awgldk - TriplyDB

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

http://www.wikidata.org/entity/Q39374494

about

The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections Genetically Engineered Phages: a Review of Advances over the Last Decade Bacteriophages and phage-derived proteins--application approaches Removal of endotoxins from bacteriophage preparations by extraction with organic solvents.Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes.Outer membrane proteins ail and OmpF of Yersinia pestis are involved in the adsorption of T7-related bacteriophage Yep-phi.Therapeutic and prophylactic applications of bacteriophage components in modern medicine.A Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial Organisms Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.Phage therapy: eco-physiological pharmacology.Genetically modified bacteriophages.Genetically modified bacteriophages in applied microbiology.The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages.Mathematical modelling of CRISPR-Cas system effects on biofilm formation.Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics.Properties and mutation studies of a bacteriophage-derived chimeric recombinant staphylolytic protein P128: Comparison to recombinant lysostaphin.Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.Efficacy of anti-staphylococcal protein P128 for the treatment of canine pyoderma: potential applications.Staphylococcus bacteriophage tails with bactericidal properties: new findings.

P2860

Q21131311-DBCCC6D5-5A28-4C32-A741-D69B839370F2 Q26744156-544C0EB5-19C0-484F-B11E-5D6C70E95B56 Q28082731-F4F039DF-EAE0-4365-B0DD-CF77352AD315 Q35219507-C36A63AA-1CCD-4EDD-ABFC-AD1B65763AC8 Q37019227-E0C66A1E-95FA-4712-A5BA-4FFB31CEAEA7 Q37254321-54A1359F-051B-418E-8903-EF945785D530 Q37406274-A17110C7-B41C-4A51-90D3-25C36B50B6E2 Q37727839-104C8884-2D17-4EC9-8E21-19718A3C5BA4 Q38215724-4940329C-7A83-4F9A-AD26-4AAD6A114313 Q38230407-767A446B-BA23-4EBD-9D9B-E843755A6AC0 Q38746993-D2A5C203-F3BD-4D88-8334-96BFE16432C7 Q38870317-FAD3F789-F05A-4238-B83F-36C26C34F876 Q39083103-5C4F522F-C32F-43FF-B5CE-403E46107B10 Q40244123-197AD8C2-FD78-4874-B6B7-3F71B22CBB59 Q40758225-901C6A66-D193-40F7-81BA-3106434FA0AA Q42126654-03B6BC4C-60F6-4A8B-A63C-836E5555F032 Q48293875-8B6A57CF-2B8A-47A4-8AB9-0961CB452FBD Q51005740-3C0A600C-46C9-415C-84F5-BB22BDB4271B Q51878166-7F7EA8F1-CFF1-4D84-9C6F-A4526118E4B1

P2860

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

http://www.wikidata.org/entity/Q39374494

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

@en

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

@nl

type

label

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

@en

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

@nl

prefLabel

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

@en

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

@nl

P1433

Q39374494-471F1636-A12C-4F02-A1B9-EACBC1830C03

P1476

Q39374494-2D9F26C5-2F04-48B7-B1B9-2D335EED36E9

P2093

Q39374494-2953A147-920E-4C69-A9C3-2ED6FEE59A31

Q39374494-566EB9EE-F9B0-4517-8B08-1ABED1D30514

Q39374494-AB1F4339-6249-46A6-B2C2-A03F2DBAC566

Q39374494-AF76A239-AF59-48C6-923B-DF01FFB6937A

Q39374494-B4D5E74E-DA72-4D56-8404-65AAC6F4F541

Q39374494-CE4B57F1-2501-4B4E-A109-B68A7D171DB4

Q39374494-E1716E86-9FDE-47E9-99CF-BC4418A56472

Q39374494-F137B33F-95DF-4166-B619-5FF3485A3461

P2860

Q39374494-0957FE1F-3E0F-4CA9-80D6-37C32855F779

Q39374494-095B363C-B4FC-4CDC-94D9-73D4173ADA0B

Q39374494-0BEEDF5C-DCD1-4047-8880-8D4F5A7D1B27

Q39374494-1453CF48-3E57-4616-82E0-7ECDD2067908

Q39374494-280286E6-25EB-490D-979D-FC7C3A0D043F

Q39374494-343143D7-B23D-4759-96B4-F9FF66581EF8

Q39374494-37BF1184-DF11-4658-B660-71FAFE4C73C5

Q39374494-3919FA60-33B0-4AE0-86BB-F02963045FA0

Q39374494-5119A180-5554-4DBF-86C9-48A17D8ED972

Q39374494-555F73CB-F7BD-438B-BE7F-3F30AFBDC90F

P2888

Q39374494-ABB67188-3128-4D37-B9AB-62577E56F157

P304

Q39374494-E5262589-DA6A-4BBA-BEAB-050B9D9BAF9E

P31

Q39374494-46247615-E0BD-4C44-A2A5-4E4DFD3ACCBB

P356

Q39374494-BCBDF875-37C1-47B3-B3D3-CCE46EBD2026

P478

Q39374494-3D431C7F-0132-455E-BC46-13943A7B36D6

P577

Q39374494-4702C275-63B6-4B95-9501-92ABCE562F68

P5875

Q39374494-3BE61751-02C3-4DD6-83EC-10E92F77C8EB

P6179

Q39374494-87B47026-96C2-422B-ABA2-16CA018A1AC5

P698

Q39374494-34DD6C3B-502C-4910-A409-595353E6BA36

P932

Q39374494-F7D28284-D9EE-4463-869E-2E34042A0228

P356

1471-2180-11-195

P1433

BMC Microbiology

P1476

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

@en

P2093

Bharathi Sriram

http://www.w3.org/2001/XMLSchema#string

Janakiraman Ramachandran

http://www.w3.org/2001/XMLSchema#string

Nanjundappa Kempashanaiah

http://www.w3.org/2001/XMLSchema#string

Sanjeev Saravanan Rajagopalan

http://www.w3.org/2001/XMLSchema#string

Sriram Padmanabhan

http://www.w3.org/2001/XMLSchema#string

Sudarson Sundarrajan

http://www.w3.org/2001/XMLSchema#string

Sukumar Hariharan

http://www.w3.org/2001/XMLSchema#string

Vivek Daniel Paul

http://www.w3.org/2001/XMLSchema#string

P2860

GeneMark.hmm: new solutions for gene finding

Bacteriophage lysis: mechanism and regulation

Dispersing biofilms with engineered enzymatic bacteriophage

Basic local alignment search tool

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

Cloning of genes affecting capsule expression in Staphylococcus aureus strain M.

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Bacteriophage holins: deadly diversity.

Staphylococcus aureus resistant to vancomycin--United States, 2002.

The prospect for bacteriophage therapy in Western medicine.

P2888

1471-2180-11-195

P304

195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2180-11-195

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51607847

http://www.w3.org/2001/XMLSchema#string

P6179

1018370954

http://www.w3.org/2001/XMLSchema#string

P698

21880144

http://www.w3.org/2001/XMLSchema#string

P932

3224134

http://www.w3.org/2001/XMLSchema#string